NACKYOUNG YOON: Open Payments
NPI 1073366753 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 31 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $503 · 2025 $747
Food & beverage: $738Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $325 |
| Janssen Biotech, Inc. | 1 | $150 |
| Amgen Inc. | 4 | $75 |
| UCB, Inc. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| GENZYME CORPORATION | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Incyte Corporation | 1 | $19 |
| Botanix SB Inc | 1 | $14 |
Products named: SKYRIZI, TREMFYA, RINVOQ, Otezla, Bimzelx, Rhapsido, DUPIXENT, Sotyktu.
Industry payments across CA — which companies pay providers there.
